---
title: "Adaptive Biotechnologies to report Q2 2026 results after market close, host conference call"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292237426.md"
description: "Adaptive Biotechnologies will report its Q2 2026 financial results after market close on July 29, 2026. A webcast conference call to discuss these results is scheduled for the same day at 1:30 p.m. PT / 4:30 p.m. ET."
datetime: "2026-07-09T20:06:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292237426.md)
  - [en](https://longbridge.com/en/news/292237426.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292237426.md)
generator: "portal-rs"
---

# Adaptive Biotechnologies to report Q2 2026 results after market close, host conference call

-   Adaptive Biotechnologies schedules Q2 2026 financial results release for July 29, 2026. \* Webcast conference call set for July 29, 2026 at 1:30 p.m. PT / 4:30 p.m. ET via here. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607091605PRIMZONEFULLFEED9759799) on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)

## Related News & Research

- [Adaptive Biotechnologies director Peter M. Neupert disposes of 124,690 common shares for $3.14 million](https://longbridge.com/en/news/296412930.md)
- [Adaptive Biotechnologies Director Sold Shares Worth Over $3.1M](https://longbridge.com/en/news/296413222.md)
- [Equifax declares Q3 2026 distribution of R$ 2.02 per unit, payable Sept. 22](https://longbridge.com/en/news/296941296.md)
- [Adaptive Biotechnologies Director Sold Shares Worth Over $748K](https://longbridge.com/en/news/296540760.md)
- [Voltalia updates financial calendar with half-year 2026 results release](https://longbridge.com/en/news/296937967.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**